A.P. Pharma appoints new VP finance, CFO
REDWOOD CITY, Calif. A.P. Pharma has appointed a new VP finance and CFO, the specialty drug maker announced.
John Whelan was appointed to the role, effective Feb. 23. Whelan replaces Gregory Turnbull, who served as interim CFO and will remain a company director and member of the board’s executive committee.
“John’s expertise in financial operations and significant general management experience make him a valuable asset and addition to A.P. Pharma’s management team,” A.P. Pharma president and CEO Ronald Prentki stated. “I would also like to thank Greg Turnbull for his contributions as interim CFO, and although we will miss his involvement with the company’s daily activities, we are fortunate that we will continue to benefit from his contributions as a member of our board of directors.”
Take Care Health Systems opens New Orleans clinic
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has opened a new clinic in the New Orleans area.
The new location makes four Take Care Clinics in that market. In total, the clinic operator has 332 clinics in 35 markets throughout 19 states.
Eli Lilly’s chemotherapy drug granted tentative approval by FDA
ROCKVILLE, Md. The Food and Drug Administration has given tentative approval to a generic version of Eli Lilly & Co.’s chemotherapy drug Gemzar, agency records show.
The FDA issued the tentative approval Monday to Hospira’s 2 g gemcitabine hydrochloride injection. The drug is used to treat non-small cell lung cancer, pancreatic cancer, ovarian, breast cancer and others.
Gemzar had worldwide sales of $1.6 billion in 2007, according to Lilly financial data. According to the FDA Orange Book, the drug will lose patent protection next year.